Logomix

Logomix (logomix.bio): no confident changes recorded yet.

The homepage shows no content without JavaScript, so the latest live check could not read it. Last tried 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

Companies in the same space

Competitors picked by an AI model from the funded startups with the most similar descriptions, judged on those descriptions only. A reading, not a verified market map.

Replay replay.bioPartial overlapBoth develop genome‑writing platforms and iPSC‑related tools for next‑generation therapeutics and cell products.
Tome Biosciences tome.bioPartial overlapBoth build programmable genomic integration platforms used to create engineered cell therapies.
Synthego synthego.comPartial overlapBoth offer large‑scale genome engineering platforms that support drug discovery and therapeutic development.
Tessera Therapeutics tesseratherapeutics.comPartial overlapBoth focus on genome‑writing technologies aimed at enabling new therapeutic and cell‑based products.

Cite this record

StartupHistory, “Logomix” company record, https://startuphistory.org/c/logomix.bio

Machine-readable: /c/logomix.bio.json. How changes are found: method.